Subscribe To
Canaccord genuity calls zynerba "undervalued," reiterates buy rating after positive 4q results
Canaccord Genuity (TSX:CF, LSE:CF) said it continued to believe that Zynerba pharmaceuticals (NASDAQ:ZY...
March 2, 2022, 11:59 am
Astrazeneca: your opportunity is knocking
The company has the highest gross margin among the top 15 pharmaceutical companies in terms of revenue,...
March 2, 2022, 11:52 am
Astrazeneca: your opportunity is knocking
The company has the highest gross margin among the top 15 pharmaceutical companies in terms of revenue,...
March 2, 2022, 11:52 am
Astrazeneca: your opportunity is knocking
The company has the highest gross margin among the top 15 pharmaceutical companies in terms of revenue,...
March 2, 2022, 11:52 am
Why jazz pharmaceuticals shares are rising
Jazz pharmaceuticals PLC (NASDAQ: JAZZ) shares are trading higher by 10.5% at $151.00 after the company...
March 2, 2022, 11:03 am
Why jazz pharmaceuticals shares are rising
Jazz pharmaceuticals PLC (NASDAQ: JAZZ) shares are trading higher by 10.5% at $151.00 after the company...
March 2, 2022, 11:03 am
Why jazz pharmaceuticals shares are rising
Jazz pharmaceuticals PLC (NASDAQ: JAZZ) shares are trading higher by 10.5% at $151.00 after the company...
March 2, 2022, 11:03 am
Is xbi etf a buy or sell in 2022 for etf investors?
The outlook for the pharmaceutical and biotech industry is good thanks to resilience versus crises and ...
March 2, 2022, 10:56 am
Is xbi etf a buy or sell in 2022 for etf investors?
The outlook for the pharmaceutical and biotech industry is good thanks to resilience versus crises and ...
March 2, 2022, 10:56 am
Is xbi etf a buy or sell in 2022 for etf investors?
The outlook for the pharmaceutical and biotech industry is good thanks to resilience versus crises and ...
March 2, 2022, 10:56 am
Jazz q4 earnings top, sales ride on new & acquired drugs
JAZZ's product revenues grow in the fourth quarter on the back of strong demand for its new drugs and drugs added with the acquisition of GW ...
March 2, 2022, 10:42 am
Jazz q4 earnings top, sales ride on new & acquired drugs
JAZZ's product revenues grow in the fourth quarter on the back of strong demand for its new drugs and drugs added with the acquisition of GW ...
March 2, 2022, 10:42 am
Jazz q4 earnings top, sales ride on new & acquired drugs
JAZZ's product revenues grow in the fourth quarter on the back of strong demand for its new drugs and drugs added with the acquisition of GW ...
March 2, 2022, 10:42 am
Has hepion pharmaceuticals, inc. (hepa) outpaced other medical stocks this year?
Here is how Hepion pharmaceuticals, Inc. (HEPA) and BioDelivery Sciences International (BDSI) have perf...
March 2, 2022, 10:42 am
Has hepion pharmaceuticals, inc. (hepa) outpaced other medical stocks this year?
Here is how Hepion pharmaceuticals, Inc. (HEPA) and BioDelivery Sciences International (BDSI) have perf...
March 2, 2022, 10:42 am
Has hepion pharmaceuticals, inc. (hepa) outpaced other medical stocks this year?
Here is how Hepion pharmaceuticals, Inc. (HEPA) and BioDelivery Sciences International (BDSI) have perf...
March 2, 2022, 10:42 am
Intercept pharmaceuticals, inc. (icpt) ceo jerry durso on q4 2021 results - earnings call transcript
Intercept pharmaceuticals, Inc. (ICPT) CEO Jerry Durso on Q4 2021 Results - Earnings Call Transcript...
March 2, 2022, 10:17 am
Intercept pharmaceuticals, inc. (icpt) ceo jerry durso on q4 2021 results - earnings call transcript
Intercept pharmaceuticals, Inc. (ICPT) CEO Jerry Durso on Q4 2021 Results - Earnings Call Transcript...
March 2, 2022, 10:17 am
Intercept pharmaceuticals, inc. (icpt) ceo jerry durso on q4 2021 results - earnings call transcript
Intercept pharmaceuticals, Inc. (ICPT) CEO Jerry Durso on Q4 2021 Results - Earnings Call Transcript...
March 2, 2022, 10:17 am
Intercept pharmaceuticals (icpt) reports q4 loss, tops revenue estimates
Intercept (ICPT) delivered earnings and revenue surprises of 2.38% and 0.56%, respectively, for the quarter ended December 2021. Do the numbers hold c...
March 2, 2022, 9:57 am